Annual Total Long Term Liabilities
$34.38 M
+$22.08 M+179.56%
December 31, 2023
Summary
- As of March 6, 2025, CASI annual total long term liabilities is $34.38 million, with the most recent change of +$22.08 million (+179.56%) on December 31, 2023.
- During the last 3 years, CASI annual total long term liabilities has risen by +$18.19 million (+112.40%).
- CASI annual total long term liabilities is now at all-time high.
Performance
CASI Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$35.03 M
+$2.36 M+7.23%
September 1, 2024
Summary
- As of March 6, 2025, CASI quarterly total long term liabilities is $35.03 million, with the most recent change of +$2.36 million (+7.23%) on September 1, 2024.
- Over the past year, CASI quarterly long term liabilities has increased by +$653.00 thousand (+1.90%).
- CASI quarterly long term liabilities is now at all-time high.
Performance
CASI Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
CASI Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +179.6% | +1.9% |
3 y3 years | +112.4% | +1.9% |
5 y5 years | +10000.0% | +1.9% |
CASI Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +179.6% | at high | +192.7% |
5 y | 5-year | at high | +3273.6% | at high | +4875.9% |
alltime | all time | at high | -100.0% | at high | -100.0% |
CASI Pharmaceuticals Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $35.03 M(+7.2%) |
Jun 2024 | - | $32.67 M(-3.9%) |
Mar 2024 | - | $34.00 M(-1.1%) |
Dec 2023 | $34.38 M(+179.6%) | $34.38 M(+187.3%) |
Sep 2023 | - | $11.97 M(-1.3%) |
Jun 2023 | - | $12.12 M(-0.1%) |
Mar 2023 | - | $12.13 M(-1.3%) |
Dec 2022 | $12.30 M(-28.3%) | $12.30 M(-17.7%) |
Sep 2022 | - | $14.94 M(-7.1%) |
Jun 2022 | - | $16.08 M(-5.3%) |
Mar 2022 | - | $16.98 M(-1.0%) |
Dec 2021 | $17.15 M(+6.0%) | $17.15 M(+2.1%) |
Sep 2021 | - | $16.80 M(-1.2%) |
Jun 2021 | - | $17.01 M(+6.8%) |
Mar 2021 | - | $15.93 M(-1.6%) |
Dec 2020 | $16.18 M(+1488.3%) | $16.18 M(+1.9%) |
Sep 2020 | - | $15.88 M(+433.6%) |
Jun 2020 | - | $2.98 M(+322.9%) |
Mar 2020 | - | $704.00 K(-30.9%) |
Dec 2019 | $1.02 M(+1277.0%) | $1.02 M(-21.1%) |
Sep 2019 | - | $1.29 M(-20.9%) |
Jun 2019 | - | $1.63 M(-11.4%) |
Mar 2019 | - | $1.84 M(+2390.8%) |
Dec 2018 | $74.00 K(-95.1%) | $74.00 K(+11.1%) |
Sep 2018 | - | $66.60 K(-95.7%) |
Jun 2018 | - | $1.55 M(+3.7%) |
Mar 2018 | - | $1.50 M(+0.0%) |
Dec 2017 | $1.50 M(-73.3%) | $1.50 M(-63.8%) |
Sep 2017 | - | $4.13 M(+0.4%) |
Jun 2017 | - | $4.12 M(-0.2%) |
Mar 2017 | - | $4.13 M(-26.4%) |
Dec 2016 | $5.61 M(-48.3%) | $5.61 M(-9.0%) |
Sep 2016 | - | $6.17 M(-3.0%) |
Jun 2016 | - | $6.36 M(-14.9%) |
Mar 2016 | - | $7.47 M(-31.2%) |
Dec 2015 | $10.86 M(+0.4%) | $10.86 M(-0.0%) |
Sep 2015 | - | $10.86 M(+15.1%) |
Jun 2015 | - | $9.44 M(+0.1%) |
Mar 2015 | - | $9.43 M(-12.8%) |
Dec 2014 | $10.81 M(>+9900.0%) | $10.81 M(+0.0%) |
Sep 2014 | - | $10.81 M(>+9900.0%) |
Jun 2014 | - | $0.00(0.0%) |
Mar 2014 | - | $0.00(0.0%) |
Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2013 | - | $0.00(0.0%) |
Jun 2013 | - | $0.00(0.0%) |
Mar 2013 | - | $0.00(0.0%) |
Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2012 | - | $0.00(0.0%) |
Jun 2012 | - | $0.00(0.0%) |
Mar 2012 | - | $0.00(0.0%) |
Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2011 | - | $0.00(0.0%) |
Jun 2011 | - | $0.00(0.0%) |
Mar 2011 | - | $0.00(0.0%) |
Dec 2010 | $0.00 | $0.00(0.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2010 | - | $0.00(0.0%) |
Jun 2010 | - | $0.00(0.0%) |
Mar 2010 | - | $0.00(-100.0%) |
Dec 2009 | $723.80 K(-92.1%) | $723.80 K(-75.3%) |
Sep 2009 | - | $2.93 M(-42.3%) |
Jun 2009 | - | $5.08 M(-29.1%) |
Mar 2009 | - | $7.16 M(-22.1%) |
Dec 2008 | $9.19 M(-45.3%) | $9.19 M(-17.7%) |
Sep 2008 | - | $11.16 M(-14.7%) |
Jun 2008 | - | $13.08 M(-12.5%) |
Mar 2008 | - | $14.95 M(-11.0%) |
Dec 2007 | $16.79 M(>+9900.0%) | $16.79 M(-9.7%) |
Sep 2007 | - | $18.58 M(>+9900.0%) |
Jun 2007 | - | $83.10 K(-27.2%) |
Mar 2007 | - | $114.20 K(-18.7%) |
Dec 2006 | $140.40 K(-39.0%) | $140.40 K(-47.7%) |
Sep 2006 | - | $268.40 K(-47.9%) |
Jun 2006 | - | $514.90 K(-31.7%) |
Mar 2006 | - | $754.10 K(+227.6%) |
Dec 2005 | $230.20 K(-45.1%) | $230.20 K(-6.7%) |
Sep 2005 | - | $246.60 K(-20.4%) |
Jun 2005 | - | $309.90 K(-2.9%) |
Mar 2005 | - | $319.30 K(-23.9%) |
Dec 2004 | $419.60 K(-19.7%) | $419.60 K(-18.9%) |
Sep 2004 | - | $517.60 K(-0.5%) |
Jun 2004 | - | $520.20 K(+4.3%) |
Mar 2004 | - | $498.80 K(-4.6%) |
Dec 2003 | $522.80 K(+42.6%) | $522.80 K(+68.7%) |
Sep 2003 | - | $309.90 K(+29.8%) |
Jun 2003 | - | $238.70 K(-9.1%) |
Mar 2003 | - | $262.60 K(-28.3%) |
Dec 2002 | $366.50 K(-83.9%) | $366.50 K(-89.4%) |
Sep 2002 | - | $3.46 M(-24.1%) |
Jun 2002 | - | $4.56 M(+37.3%) |
Mar 2002 | - | $3.32 M(+46.3%) |
Dec 2001 | $2.27 M(+126.0%) | $2.27 M(-0.7%) |
Sep 2001 | - | $2.29 M(-10.5%) |
Jun 2001 | - | $2.56 M(-9.3%) |
Mar 2001 | - | $2.82 M(+180.3%) |
Dec 2000 | $1.01 M(-49.6%) | $1.01 M(-19.9%) |
Sep 2000 | - | $1.26 M(-16.7%) |
Jun 2000 | - | $1.51 M(-14.0%) |
Mar 2000 | - | $1.75 M(-12.1%) |
Dec 1999 | $2.00 M(+66.3%) | $2.00 M(+1895.3%) |
Jun 1999 | - | $100.00 K(0.0%) |
Mar 1999 | - | $100.00 K(-85.7%) |
Sep 1998 | - | $700.00 K(-30.0%) |
Jun 1998 | - | $1.00 M(-9.1%) |
Mar 1998 | - | $1.10 M(-8.3%) |
Dec 1997 | $1.20 M(-45.5%) | $1.20 M(-29.4%) |
Sep 1997 | - | $1.70 M(-10.5%) |
Jun 1997 | - | $1.90 M(-13.6%) |
Mar 1997 | - | $2.20 M(0.0%) |
Dec 1996 | $2.20 M | $2.20 M(-4.3%) |
Sep 1996 | - | $2.30 M(0.0%) |
Jun 1996 | - | $2.30 M(-8.0%) |
Mar 1996 | - | $2.50 M |
FAQ
- What is CASI Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals annual total long term liabilities year-on-year change?
- What is CASI Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals quarterly long term liabilities year-on-year change?
What is CASI Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of CASI is $34.38 M
What is the all time high annual total long term liabilities for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high annual total long term liabilities is $34.38 M
What is CASI Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, CASI annual total long term liabilities has changed by +$22.08 M (+179.56%)
What is CASI Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of CASI is $35.03 M
What is the all time high quarterly long term liabilities for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high quarterly total long term liabilities is $35.03 M
What is CASI Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, CASI quarterly total long term liabilities has changed by +$653.00 K (+1.90%)